Internal Medicine, Pulmonary Disease · Brooklyn, NY
NPI
1598719585
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1958 Ocean Ave
Brooklyn, NY, 11230
Phone (718) 645-8901
Groups this clinician bills Medicare through
Medicare paid, 2024
$341K
3,887 services
Medicare patients, 2024
1,012
Average age 74
Drug cost, 2024
$4.6M
20,237 prescriptions
Company payments, 2025
$1,447
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reuven Moshenyat was code 99213 (office e&m - established), 1,725 times for 772 patients. In total Reuven Moshenyat billed 3,887 services in 13 codes, and Medicare paid $341K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,725 | 772 | $81.63 | $141K |
| 94060 Pulmonary Function Testing | Office | 484 | 470 | $36.20 | $18K |
| 94729 Pulmonary Function Testing | Office | 474 | 461 | $53.12 | $25K |
| 94727 Pulmonary Function Testing | Office | 467 | 454 | $41.39 | $19K |
| 99441 Telephone Services | Office | 224 | 171 | $50.04 | $11K |
| 99203 Office E&M - New | Office | 185 | 185 | $100.76 | $19K |
| 99204 Office E&M - New | Office | 165 | 165 | $151.85 | $25K |
| 95811 Sleep Study | Office | 81 | 81 | $610.54 | $49K |
| 95810 Sleep Study | Office | 55 | 55 | $573.86 | $32K |
| 95806 Sleep Study | Office | 16 | 16 | $81.74 | $1,308 |
By year: 2022 $357K for 4,181 services; 2023 $351K for 4,136 services; 2024 $341K for 3,887 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reuven Moshenyat prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 5,796 prescriptions and refills. In total Reuven Moshenyat wrote 20,237 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 5,796 | 6,277 | 1,257 | $180K |
| Arnuity Ellipta Fluticasone Furoate | 2,723 | 2,841 | 666 | $731K |
| Montelukast Sodium Generic | 1,332 | 1,711 | 249 | $9,134 |
| Ventolin Hfa Albuterol Sulfate | 1,278 | 1,496 | 309 | $74K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 970 | 1,074 | 187 | $660K |
| Incruse Ellipta Umeclidinium Bromide | 904 | 955 | 194 | $320K |
| Breo Ellipta Fluticasone/Vilanterol | 728 | 768 | 150 | $295K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 583 | 613 | 126 | $375K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 568 | 627 | 156 | $78K |
| Prednisone Generic | 555 | 561 | 274 | $792 |
| Spiriva Respimat Tiotropium Bromide | 405 | 491 | 82 | $240K |
| Azithromycin Generic | 344 | 344 | 256 | $1,238 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 340 | 365 | 93 | $62K |
| Levofloxacin Generic | 308 | 308 | 222 | $905 |
| Symbicort Budesonide/Formoterol Fumarate | 300 | 336 | 95 | $74K |
Brand drugs: 14,084 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reuven Moshenyat $1,447 ($1,447 in general payments such as food, travel and fees) from 7 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $900.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.